RASA2 and neoplasm: Another unbiased in vitro CRISPR screen identified that knocking out RASA2 in T cells could maintain the ability to eliminate tumour cells even with repeated exposure to antigens, which was achieved through elevated expression of genes related to cell cycle, mitochondria, fatty acid metabolism, and enhanced TCR signal transduction [131].